对现有前列腺影像报告和数据系统第2版(PI-RADSv2)文献的系统综述及按Gleason评分分层的PI-RADSv2分类子集Meta分析
该系统综述与Meta分析检索截至2018年4月1日的英文文献,纳入59项研究,其中13项进入Meta分析,评估PI-RADSv2各评分中Gleason评分≥3+4的比例。结果显示PI-RADSv2评分1/2、3、4、5分别约有6%、12%、48%、72%为高级别病变,PI-RADSv2以≥3分为阳性阈值时敏感性良好,但文献异质性高。
要点
- PI-RADSv2评分1/2、3、4、5病灶中Gleason评分≥3+4的比例分别约为6%、12%、48%、72%。
- PI-RADSv2评分为3分及以上时,Gleason评分≥3+4的患病率约为45%。
- 以PI-RADSv2≥3分为阳性阈值时,PI-RADSv2显示出良好的敏感性。
核心结论
- 尽管文献高度异质,Meta分析显示PI-RADSv2以≥3分为阳性阈值时具有良好的敏感性;各评分中高级别病变比例随评分升高而增加。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,仅纳入截至2018年4月1日的英文文献;检索到434条题录,纳入59项研究,其中13项有足够数据进入Meta分析;采用Stata 13.1随机效应模型计算合并估计值和95%CI。
关键影像表现/征象
- PI-RADSv2评分1或2的病灶中约6%为高级别病变。
- PI-RADSv2评分3的病灶中约12%为高级别病变。
- PI-RADSv2评分4的病灶中约48%为高级别病变。
- PI-RADSv2评分5的病灶中约72%为高级别病变。
诊断标准与关键数值
- PI-RADSv2评分1或2、3、4、5对应的Gleason评分≥3+4比例分别约为6%、12%、48%、72%。
- PI-RADSv2评分≥3的病灶中Gleason评分≥3+4的患病率约为45%。
- 以PI-RADSv2≥3分为阳性阈值时,PI-RADSv2具有良好的敏感性。
临床应用与阅片要点
- 阅读PI-RADSv2文献时需注意术语、患者队列选择、诊断标准、成像参数和参考标准的差异。
- 报告PI-RADSv2评分时,可参考各评分对应的Gleason评分≥3+4比例。
局限性
- 现有PI-RADSv2文献在技术和术语上具有显著多样性。
- 由于术语、患者队列选择、标准、成像参数和参考标准的变化,数据高度异质且难以分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of this study was to quantitatively and qualitatively assess the methodologic heterogeneity of the current Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) literature and estimate the proportions of Gleason scores (GSs) diagnosed across PI-RADSv2 categories.
MATERIALS AND METHODS: This study was a systematic review and meta-analysis and was performed in concordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Only English-language studies and studies published before April 1, 2018, were assessed. The primary outcome of the meta-analysis was the estimated percentage of patients with GS ≥ 3 + 4 within each individual PI-RADSv2 score. We calculated the pooled estimates and 95% CIs on the basis of a random-effects model using the meta-analysis routine of Stata (version 13.1).
RESULTS: Our search revealed 434 titles, and 59 of these studies were selected. These studies were remarkable for their technical and terminological diverseness. Thirteen studies had sufficient data to be included in the meta-analysis. The prevalence of ≥ GS 3 + 4 in lesions assigned a PI-RADSv2 score of 3 or higher was approximately 45%. Lesions assigned PI-RADSv2 scores 1 or 2, 3, 4, and 5 represented high-grade disease in approximately 6%, 12%, 48%, and 72% of patients.
CONCLUSION: The data available in the literature are highly heterogeneous and challenging to analyze because of variations in terminology, patient cohort selection, criteria, imaging parameters, and reference standards. In spite of this heterogeneity, our meta-analysis shows that PI-RADSv2 has good sensitivity when a score of ≥ 3 is considered as a positive test.
引用
- Barkovich EJ, Shankar PR, Westphalen AC, et al. A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores. AJR Am J Roentgenol. 2019. PMID: 30807218. doi:10.2214/AJR.18.20571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。